drugset / Trial / NCT02991222

Bioavailability Study of SPARC001(Study 1) in Healthy Adult Volunteers

NCT02991222

Phase 1 Completed 24 enrolled Sun Pharma Advanced Research Company Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The objective of the study is to determine the relative bioavailability, safety and tolerability of SPARC001 and Reference001 in healthy, adult, male and female subjects

Timeline

Start
2017-01-15
Primary completion
2017-02-15
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Reference001 Unknown
Subject SPARC001 Unknown

Indications

No indication recorded.